QIAGEN

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell QIAGEN and other ETFs, options, and stocks.

About QGEN

QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. Its sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials. 

CEO
Jonathan M. Pratt
CEOJonathan M. Pratt
Employees
5,654
Employees5,654
Headquarters
Venlo, Limburg
HeadquartersVenlo, Limburg
Founded
1996
Founded1996
Employees
5,654
Employees5,654

QGEN Key Statistics

Market cap
9.38B
Market cap9.38B
Price-Earnings ratio
23.08
Price-Earnings ratio23.08
Dividend yield
0.77%
Dividend yield0.77%
Average volume
2.28M
Average volume2.28M
High today
$46.37
High today$46.37
Low today
$45.47
Low today$45.47
Open price
$45.84
Open price$45.84
Volume
1.47M
Volume1.47M
52 Week high
$57.82
52 Week high$57.82
52 Week low
$32.53
52 Week low$32.53

Stock Snapshot

QIAGEN(QGEN) stock is priced at $45.56, giving the company a market capitalization of 9.38B. It carries a P/E multiple of 23.08 and pays a dividend yield of 0.77%.

On 2026-10-15, QIAGEN(QGEN) stock traded between a low of $45.47 and a high of $46.37. Shares are currently priced at $45.56, which is +0.2% above the low and -1.7% below the high.

QIAGEN(QGEN) shares are trading with a volume of 1.47M, against a daily average of 2.28M.

During the past year, QIAGEN(QGEN) stock moved between $32.53 at its lowest and $57.82 at its peak.

During the past year, QIAGEN(QGEN) stock moved between $32.53 at its lowest and $57.82 at its peak.

QGEN News

TipRanks 11h
BlackRock Discloses Significant Stake in Qiagen via AFM Filing

Qiagen ( (QGEN) ) just unveiled an update. Qiagen N.V. has disclosed a notification from the Netherlands Authority for the Financial Markets (AFM) reporting th...

TipRanks 22h
Qiagen price target raised to $55 from $50 at JPMorgan

JPMorgan raised the firm’s price target on Qiagen (QGEN) to $55 from $50 and keeps an Overweight rating on the shares. The firm updated models in the life scien...

Investing.com 1d
QIAGEN hosts global TB summit as funding cuts threaten programs - Investing.com

...

QIAGEN hosts global TB summit as funding cuts threaten programs - Investing.com

Analyst ratings

55%

of 20 ratings
Buy
45%
Hold
55%
Sell
0%

More QGEN News

Simply Wall St 2d
Did AI Research Tools Just Shift Qiagen's Investment Narrative?

Qiagen recently introduced new AI driven tools for biological and genomic research and gained U.S. FDA clearance for a gram negative bloodstream infection panel...

Did AI Research Tools Just Shift Qiagen's Investment Narrative?
Simply Wall St 7d
Qiagen Stock Looks Cheap Based On Future Cash Flow

shares have delivered a 13.3% gain over the past three years, while the company has been pushing deeper into areas like AI driven bioinformatics and automated d...

Qiagen Stock Looks Cheap Based On Future Cash Flow

People also own

Based on the portfolios of people who own QGEN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.